Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects
This study has been completed.
Study NCT00392925   Information provided by Amylin Pharmaceuticals, LLC.

First Received on October 24, 2006.   Last Updated on September 19, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Overweight
Obesity
Additional conditions recognized in this trial
Body Weight
More general conditions related to this trial
Nutrition Disorders
Overnutrition
Signs and Symptoms
Interventions listed in this trial
pramlintide acetate
recombinant-methionyl human leptin
placebo
Additional drug interventions recognized in this trial
Islet Amyloid Polypeptide
Pramlintide
More general drug interventions related to this trial
Anti-Obesity Agents
Appetite Depressants
Central Nervous System Agents
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Amylin Pharmaceuticals, LLC.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services